Cubist Systematic Strategies, LLC Guardant Health, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 526,536 shares of GH stock, worth $22.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

526,536

Previous 13,300 3858.92%

Holding current value

$22.5 Million

Previous $304,000 5191.12%

% of portfolio

0.11%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$20.2 - $38.11 $10.6 Million - $20.1 Million	526,536 New	526,536 $16.1 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $4.96 Million - $9.83 Million	308,621 Added 471.11%	374,130 $10.8 Million
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $4.95 Million - $7.78 Million	-288,985 Reduced 81.52%	65,509 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $7.65 Million - $10.5 Million	354,494 New	354,494 $9.59 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $8.04 Million - $11.8 Million	350,632 Added 118.0%	647,776 $15.2 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $7.31 Million - $17.2 Million	287,213 Added 2892.09%	297,144 $8.08 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $223,146 - $311,771	-5,111 Reduced 33.98%	9,931 $535,000
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $113,291 - $304,062	-3,931 Reduced 20.72%	15,042 $607,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $775,811 - $1.62 Million	16,079 Added 555.6%	18,973 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $256,726 - $348,524	2,894 New	2,894 $289,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $4.1 Million - $5.48 Million	-41,495 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $4.55 Million - $6.87 Million	41,495 New	41,495 $5.15 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $10.8 Million - $15.3 Million	-85,271 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $6.02 Million - $8.19 Million	60,259 Added 240.92%	85,271 $11 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $1.42 Million - $1.98 Million	17,687 Added 241.46%	25,012 $2.8 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $146,688 - $236,437	2,425 Added 49.49%	7,325 $594,000
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $232,322 - $349,467	3,935 Added 407.77%	4,900 $341,000
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $4.67 Million - $6.5 Million	-78,465 Reduced 98.79%	965 $75,000
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $4.41 Million - $7.77 Million	70,435 Added 783.05%	79,430 $5.07 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $468,872 - $668,109	7,333 Added 441.22%	8,995 $777,000
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $57,006 - $162,842	1,662 New	1,662 $127,000

Others Institutions Holding GH

# of Institutions

347

Shares Held

120M

Call Options Held

793K

Put Options Held

1.85M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.36B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Guardant Health, Inc. Transaction History